Advances and issues in bronchopulmonary dysplasia

Northway, 1967, Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia, N Engl J Med, 276, 357, 10.1056/NEJM196702162760701 Sinkin, 1991, Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials, Pediatrics, 86, 728, 10.1542/peds.86.5.728 Dunn, 1990, Predicting risk for bronchopulmonary dysplasia, Pediatrics, 86, 788, 10.1542/peds.86.5.788 Overstreet, 1991, Estimation of mortality risk in chronically ventilated infants with bronchopulmonary dysplasia, Pediatrics, 88, 1153, 10.1542/peds.88.6.1153 Palta, 1991, For the Newborn Lung Project, 119, 285 Tammela, 1992, The relationship of fluid restriction during the 1st month of life to the occurrence and severity of bronchopulmonary dysplasia in low birth weight infants: a 1-year radiological follow up, Eur J Pediatr, 151, 367, 10.1007/BF02113260 Van Marter, 1992, Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices, J Pediatr, 120, 938, 10.1016/S0022-3476(05)81968-7 Van Marter, 1990, Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birthweight infants, J Pediatr, 116, 942, 10.1016/S0022-3476(05)80658-4 Jefferies, 1984, Pulmonary epithelial permeability in hyaline-membrane disease, N Engl J Med, 311, 1075, 10.1056/NEJM198410253111703 O'Brodovich, 1988, Pulmonary clearance of 99mTc-DTPA in infants who subsequently develop bronchopulmonary dysplasia, Am Rev Respir Dis, 137, 210, 10.1164/ajrccm/137.1.210 Adkins, 1991, Age effects susceptibility to pulmonary barotrauma in rabbits, Crit Care Med, 19, 390, 10.1097/00003246-199103000-00018 Mills, 1991, Greater permeability of the neonatal lung: postnatal changes in surface charge and biochemistry of porcine pulmonary capillary endothelium, J Thorac Cardiovasc Surg, 101, 909, 10.1016/S0022-5223(19)36664-4 Davis, 1991, Differential effects of oxygen and barotrauma on lung injury in the neonatal piglet, Pediatr Pulmonol, 10, 157, 10.1002/ppul.1950100305 Ogden, 1983, Lung lavage of newborns with respiratory distress syndrome, Chest, 83, 315 Stefano, 1992, Soluble interleukin-2 receptor levels in infants with bronchopulmonary dysplasia, Pediatr Pulmonol, 14, 58, 10.1002/ppul.1950140111 Pitkanen, 1990, Correlation of free oxygen radical—induced lipid peroxidation with outcome in very low birthweight infants, J Pediatr, 116, 760, 10.1016/S0022-3476(05)82668-X Merritt, 1983, Elastase and α-1 proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome, J Clin Invest, 72, 656, 10.1172/JCI111015 Rosenfeld, 1984, Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome, J Pediatr, 105, 781, 10.1016/S0022-3476(84)80307-8 Smith, 1993, Oxidant stress responses in preterm infants during exposure to hyperoxia, Pediatr Res, 34, 360, 10.1203/00006450-199309000-00024 Housset, 1991, Toxic effects of oxygen on cultured alveolar epithelial cells, lung fibroblasts, and alveolar macrophages, Eur Respir J, 4, 1066, 10.1183/09031936.93.04091066 Frank, 1991, Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits, Pediatr Res, 29, 292, 10.1203/00006450-199103000-00014 Friel, 1993, Selenium status of very low birthweight infants, Pediatr Res, 34, 293, 10.1203/00006450-199309000-00010 Hallman, 1991, Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid, Am Rev Respir Dis, 144, 1376, 10.1164/ajrccm/144.6.1376 Gregory, 1991, Surfactant chemical composition in acute respiratory distress syndrome, J Clin Invest, 88, 1976, 10.1172/JCI115523 Kobayashi, 1991, Inactivation of exogenous surfactant by pulmonary edema fluid, Pediatr Res, 29, 353, 10.1203/00006450-199104000-00005 Ryan, 1991, Effects of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro, Am J Respir Cell Mol Biol, 4, 33, 10.1165/ajrcmb/4.1.33 Holm, 1991, Inhibition of pulmonary surfactant function by phospholipases, J Appl Physiol, 71, 317, 10.1152/jappl.1991.71.1.317 Wispe, 1991, Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant proteins, J Clin Invest, 86, 1954, 10.1172/JCI114929 Kobayashi, 1991, Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B, J Appl Physiol, 71, 530, 10.1152/jappl.1991.71.2.530 Parker, 1992, Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia, Pediatrics, 90, 663, 10.1542/peds.90.5.663 McAleese, 1993, Financial and emotional cost of bronchopulmonary dysplasia, Clin Pediatr, 393, 10.1177/000992289303200702 Freudenheim, 1988, In pursuit of the punctual baby, New York Times Stefano, 1991, A randomized placebo-controlled study to evaluate the effects of oral albuterol on pulmonary mechanics in ventilator-dependent infants at risk of developing BPD, Pediatr Pulmonol, 10, 183, 10.1002/ppul.1950100309 Brundage, 1990, Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia, Am Rev Respir Dis, 142, 1137, 10.1164/ajrccm/142.5.1137 Denjean, 1992, Dose-related bronchodilator response to aerosolized salbutamol (albuterol) in ventilator-dependent premature infants, J Pediatr, 120, 974, 10.1016/S0022-3476(05)81973-0 Brudno, 1989, Response of pulmonary mechanics to terbutaline in patients with bronchopulmonary dysplasia, Am J Med Sci, 273, 166, 10.1097/00000441-198903000-00007 Kazzi, 1990, Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation, Pediatrics, 86, 722, 10.1542/peds.86.5.722 Yoder, 1991, Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia, Am Rev Respir Dis, 143, 1044, 10.1164/ajrccm/143.5_Pt_1.1044 LaForce, 1993, Controlled trial of beclomethasone dipropionate by nebulization in oxygen institution, J Pediatr, 122, 285, 10.1016/S0022-3476(06)80134-4 Wilson, 1991, Nutrition and bronchopulmonary dysplasia, Arch Dis Child, 66, 37, 10.1136/adc.66.1_Spec_No.37 Puntis, 1991, Pulmonary intravascular lipid in neonatal necropsy specimens, Arch Dis Child, 66, 26, 10.1136/adc.66.1_Spec_No.26 Sosenko, 1988, Polyunsaturated fatty acids and protection of newborn rats from oxygen toxicity, J Pediatr, 112, 630, 10.1016/S0022-3476(88)80186-0 Pitkanen, 1992, Peroxidation of lipid emulsions: a hazard for the premature infant receiving parenteral nutrition?, Free Radic Biol Med, 13, 239, 10.1016/0891-5849(92)90020-H Helbock, 1993, Toxic hydroperoxides in intravenous fat emulsions used in preterm infants, Pediatrics, 91, 83, 10.1542/peds.91.1.83 Margraf, 1991, Morphometric analysis of the lung in bronchopulmonary dysplasia, Am Rev Respir Dis, 143, 391, 10.1164/ajrccm/143.2.391 Gaultier, 1991, Malnutrition and lung growth, Pediatr Pulmonol, 10, 278, 10.1002/ppul.1950100410 Watts, 1991, Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants <1500 g birthweight, Eur Respir J, 4, 188, 10.1183/09031936.93.04020188 Chytil, 1992, The lungs and vitamin A, Am J Physiol, 262, L517 Shenai, 1987, Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia, J Pediatr, 111, 269, 10.1016/S0022-3476(87)80086-0 Pearson, 1992, Trial of vitamin A supplementation in very low birthweight infants at risk for bronchopulmonary dysplasia, J Pediatr, 121, 420, 10.1016/S0022-3476(05)81800-1 Georgieff, 1989, Effect of postnatal steroid administration on serum vitamin A concentrations in newborn infants with respiratory compromise, J Pediatr, 114, 301, 10.1016/S0022-3476(89)80801-7 Jobe, 1993, Pulmonary surfactant therapy, N Engl J Med, 328, 861, 10.1056/NEJM199303253281208 Long, 1991, American Exosurf Neonatal Study Group 1: effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome, J Pediatr, 118, 595, 10.1016/S0022-3476(05)83388-8 Long, 1991, The American Exosurf Neonatal Study Group I and the Canadian Exosurf Neonatal Study Group: a controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome, N Engl J Med, 325, 1696, 10.1056/NEJM199112123252404 Corbet, 1991, American Exosurf Study Group I: decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial, J Pediatr, 118, 277, 10.1016/S0022-3476(05)80502-5 Merritt, 1991, Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birthweight infants with long immaturity, J Pediatr, 118, 581, 10.1016/S0022-3476(05)83387-6 Hennes, 1991, Surfactant replacement therapy in respiratory distress syndrome: meta-analysis of clinical trials of single-dose surfactant extracts, Am J Dis Child, 145, 102, 10.1001/archpedi.1991.02160010108027 1989, N Engl J Med, 320, 88, 10.1056/NEJM198901123200204 Tutuncu, 1993, Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: dose-dependent improvement of gas exchange, Crit Care Med, 21, 962, 10.1097/00003246-199307000-00008 Bush, 1990, Changes in pulmonary circulation in severe bronchopulmonary dysplasia, Arch Dis Child, 65, 739, 10.1136/adc.65.7.739 White, 1990, Pulmonary hypertension in bronchopulmonary dysplasia [Letter], Arch Dis Child, 65, 1378, 10.1136/adc.65.12.1378-a Sekar, 1991, Sleep apnea and hypoxemia in recently weaned premature infants with and without bronchopulmonary dysplasia, Pediatr Pulmonol, 10, 112, 10.1002/ppul.1950100213 Vohr, 1991, Neurodevelopmental and medical status of low birthweight survivors of bronchopulmonary dysplasia at 10 to 12 years of age, Dev Med Child Neurol, 33, 690, 10.1111/j.1469-8749.1991.tb14946.x Luchi, 1991, Predictors of neurodevelopmental outcome following bronchopulmonary dysplasia, Am J Dis Child, 145, 813 Teberg, 1991, Prediction of neurodevelopmental outcome in infants with and without bronchopulmonary dysplasia, Am J Med Sci, 301, 369, 10.1097/00000441-199106000-00002 Blayney, 1991, Bronchopulmonary dysplasia: improvement in lung function between 7 and 10 years of age, J Pediatr, 118, 201, 10.1016/S0022-3476(05)80483-4 DeKleine, 1990, Lung function 8–18 years after intermittent positive pressure ventilation for hyaline membrane disease, Thorax, 45, 941, 10.1136/thx.45.12.941 Northway, 1990, Late pulmonary sequelae of bronchopulmonary dysplasia, N Engl J Med, 323, 1793, 10.1056/NEJM199012273232603 Stahlman, 1989, Medical complications in premature infants, 320, 1551